Author

Lucile Monnier

Idorsia Pharmaceuticals Ltd (Switzerland)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alexandre BossuiD· 1 shared Camille Forny· 1 shared Christine BrotschiiD· 1 shared Christine Kuntz· 1 shared Eric A. ErteliD· 1 shared Florent ChevillardiD· 1 shared Jodi T. WilliamsiD· 1 shared John GatfieldiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Alexandre BossuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyScience AdvancesPeer-reviewedMar 1, 2024

A Novel, Uniquely Efficacious Type of CFTR Corrector with Complementary Mode of Action

Valentina Marchesin, Lucile Monnier, Peter Blattmann…·John Gatfield

This paper describes a novel type-IV CFTR corrector that improves folding and trafficking of F508del-CFTR, including previously resistant mutations, through a unique binding site and mechanism.

15 citations

humanexperimental assay

𝕏 PostBluesky